MWMary Elias Kamel Wahba

Mary Elias Kamel Wahba

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mary Elias Kamel Wahba has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2014
      • Vol. 61  (1) , 11-8

    Orthogonal projection to latent structures combined with artificial neural networks in non-destructive analysis of ebastine powder.

    by Fawzia Ahmed Ibrahim, Mary Elias Kamel Wahba

    A new method orthogonal projection to latent structures (O-PLS) combined with artificial neural networks is investigated for non-destructive determination of ebastine powder via near-infrared (NIR) spectroscopy. The modern NIR spectroscopy is efficient, simple and non-destructive technique, which has been used in chemical analysis in diverse fields. Being a preprocessing method, O-PLS provides a way to remove systematic variation from an input data set X not correlated to the response set Y, and does not disturb the correlation between X and Y. In this paper, O-PLS pretreated spectral data was applied to establish the ANN model of ebastine powder, in this model, the concentration of ebastine as the active component was determined. The degree of approximation was employed as the selective criterion of the optimum network parameters. In order to compare the OPLS-ANN model, the calibration models that use first-derivative and second-derivative preprocessing spectra were also designed. Experimental results showed that the OPLS-ANN model was the best.


  • Validated Spectroflurimetric Determination of Some H1 Receptor Antagonist Drugs in Pharmaceutical Preparations Through Charge Transfer Complexation

    by Mohie K. Sharaf El-Din, Fawzia Ibrahim, Manal I. Eid, Mary E. K. Wahba

    A validated simple, rapid, and selective spectrofluorimetric method was developed for the determination of some antihistaminic H1 receptor antagonist drugs namely ebastine (EBS), cetirizine dihydrochloride (CTZ), and fexofenadine hydrochloride (FXD). The method is based on the reaction of the cited drugs with some Π acceptors namely p-chloranilic acid (CLA), tetracyanoethylene (TCNE), and 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) to give highly fluorescent derivatives. The fluorescence intensity—concentration plots were rectilinear over the concentration ranges of 0.2–3.0, 0.2–2.5 and 0.15–2.0 μg/ml for EBS with CLA, DDQ, and TCNE respectively; 0.5–7.0, 0.5–6.0, and 0.2–4.0 μg/ml for CTZ with the previously mentioned reagents, and 0.2–3.5, 0.5–6.0, and 0.2–3.5 μg/ml for FXD. The factors affecting the formation of the reaction products were carefully studied and optimized. The method was applied for the determination of the studied drugs in their dosage forms. The results obtained were in good agreement with those obtained by the comparison methods. Reactions Stoichiometries of the complexes formed between the studied drugs and Π acceptors were defined by the Job’s method of the continuous variation and found in 1:1 in all cases.


  • Open Access

    Validated stability indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity testing

    by Fawzia Ibrahim, Mohie Khaled Sharaf El- Din, Manal Ibrahim Eid, Mary Elias Kamel Wahba

    An accurate, simple, sensitive and selective reversed phase liquid chromatographic method has been developed for the determination of ebastine in its pharmaceutical preparations. The proposed method depends on the complexation ability of the studied drug with Zn2+ ions. Reversed phase chromatography was conducted using an ODS C18 (150 × 4.6 mm id) stainless steel column at ambient temperature with UV-detection at 260 nm. A mobile phase containing 0.025%w/v Zn2+ in a mixture of (acetonitril/methanol; 1/4) and Britton Robinson buffer (65:35, v/v) adjusted to pH 4.2, has been used for the determination of ebastine at a flow rate of 1 ml/min. The calibration curve was rectilinear over the concentration range of 0.3 - 6.0 μg/ml with a detection limit (LOD) of 0.13 μg/ml, and quantification limit (LOQ) of 0.26 μg/ml. The proposed method was successfully applied for the analysis of ebastine in its dosage forms, the obtained results were favorably compared with those obtained by a comparison method. Furthermore, content uniformity testing of the studied pharmaceutical formulations was also conducted. The composition of the complex as well as its stability constant was also investigated. Moreover, the proposed method was found to be a stability indicating one and was utilized to investigate the kinetics of alkaline and ultraviolet induced degradation of the drug. The first-order rate constant and half life of the degradation products were calculated.


  • Open Access

    Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations

    by Fawzia Ibrahim, Mohie Khaled Sharaf El-Din, Manal Ibrahim Eid, Mary Elias Kamel Wahba

    Two sensitive, selective, economic, and validated spectrofluorimetric methods were developed for the determination of ebastine (EBS) in pharmaceutical preparations depending on reaction with its tertiary amino group. Method I involves condensation of the drug with mixed anhydrides (citric and acetic anhydrides) producing a product with intense fluorescence, which was measured at 496 nm after excitation at 388 nm.


    • 1 January 2011
      • Vol. 58  (2) , 278-287

    First and Second Derivative Synchronous Fluorescence and Spectrophotometric Spectroscopy for the Simultaneous Determination of Fexofenadine Hydrochloride in Presence of Its Degradation Products. Application to Stability Studies

    by Mohie Khaled Sharaf El-Din, Fawzia Ahmed Ibrahim, Manal Ibrahim Eid, Mary Elias Kamel Wahba

    Two rapid, simple, sensitive, selective and economic derivative spectrophotometric (first [D-1] and second [D-2]) and synchronous spectrofluorimetric (FDSFS and SDSFS) methods have been developed for the analysis of fexofenadine hydrochloride (FXD) in the presence of its different degradation products. Derivative spectrophotometry (D-1) was used to measure FXD at 223 nm in the presence of its alkaline or acidic degradation products, and at 211 nm in the presence of its oxidative degradation product. Derivative spectrophotometry (D-2) was used to determine FXD at 217 urn in the presence of its alkaline or acidic degradation products, and at 215 nm in the presence of its oxidative degradation product; the UV degradation product was measured at 211 nm. Synchronous spectrofluorimetry (FDSFS) was used to measure FXD in the presence of its alkaline or acidic degradation products at 406 nm, and at 367 nm in the presence of its oxidative or UV degradation products. Synchronous spectrofluorimetry (SDSFS) was applied to determine the drug at 225 nm in the presence of its alkaline, acidic, oxidative or UV degradation products. The proposed methods were successfully applied for the determination of the studied compound in its commercial tablets. The results obtained were in good agreement with those obtained by the comparison method.